Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001190315-07-000005
Filing Date
2007-03-05
Accepted
2007-03-05 18:55:20
Documents
2
Period of Report
2007-03-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 6057
2 EDGAR SUPPORTING DOCUMENT mathews.txt EX-24 824
  Complete submission text file 0001190315-07-000005.txt   8762
Mailing Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656
Business Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS (Issuer) CIK: 0000858803 (see all company filings)

EIN.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11388 SORRENTO VALLEY RD STE 200 SAN DIEGO CA 92121
Business Address
MATHEWS CHARLES (Reporting) CIK: 0001190315 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15803 | Film No.: 07672911